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A B S T R A C T
The human endometrium undergoes extensive morphological, biochemical and molecular changes under the
inﬂuence of female sex steroid hormones. Besides the fact that estrogen stimulates endometrial cell proliferation
and progesterone inhibits this proliferation and induces diﬀerentiation, there is limited knowledge about precise
molecular mechanisms underlying human endometrial biology. The importance of paracrine signaling in
endometrial physiology explains why in vitro culture of endometrial cells has been challenging. Researchers,
therefore, have developed alternative experimental in vivo models for the study of endometrial biology. The
objective of this review is to summarize the recent developments and work on these in vivo endometrial
research models. The in vivo recombinant tissue models in which wild-type endometrial cells are combined with
endometrial cells from a gene-targeted mouse strain followed by xenografting to host mice have been critical in
conﬁrming the signiﬁcance of paracrine signaling between the epithelium and stroma in the growth regulation
of the endometrium. Additionally, these studies have uncovered diﬀerences between the mouse and human,
emphasizing the need for the development of experimental models speciﬁcally of the human endometrium.
Recently, xenotransplants of human endometrial fragments into the subcutaneous space of host mice and
endometrial xenografts of dissociated and recombined epithelial and stromal cells beneath the kidney capsule of
immunodeﬁcient host mice have proven to be highly promising tools for in vivo research of endometrial
functions. For the ﬁrst time, the latter approach provides an immense opportunity for the application of genome
engineering, such as targeted ablation of endometrial genes for example by using CRISPR/CAS9 system. This
research will begin to elucidate the functional role of speciﬁc genes in this complex tissue. Another advantage of
xenotransplantation and xenograft models of the human endometrium is their use to investigate endometrial
eﬀects of new compounds and drugs without needing to give them to women. Underpinning the molecular
mechanisms underlying endometrial functions is critical to ultimately advance our understanding of
endometrial pathophysiology and develop targeted therapies to prevent and cure endometrial pathologies as
well as enhance endometrial function when it is desired for fertility.
1. Introduction
The human endometrium is a complex dynamic tissue comprised of
several cellular compartments including luminal and glandular epithe-
lium, stromal ﬁbroblasts, immune cells and endothelial cells. A
muscular layer known as the myometrium surrounds the endome-
trium. The endometrium is a classical sex steroid hormone target tissue
and exhibits unique properties of extensive cyclic regeneration and
transformation under the control of 17ß-estradiol (E2) and progester-
one (P) in the preparation for embryo implantation. Both E2 and P
elicit their eﬀects through the cognate receptors that are members of
the steroid receptor superfamily, ESR and PGR respectively (Evans,
1988; Hamilton et al., 2017). Estrogen receptor alpha (ESR1) appears
to be the predominant receptor in mediating E2 signaling in the uterus
(Couse et al., 1995). If no pregnancy is established, prior exposure of
the endometrium to P is necessary to induce monthly menstrual
bleeding that in turn is caused by the loss of P stimulation to allow a
new cycle to start. Inadequate exposure or reduced responsiveness of
the endometrium to P additionally exacerbates the development of
endometrial pathology, including endometrial hyperplasia and adeno-
carcinoma as well as endometriosis that are driven by E2 (Burney et al.,
2007). Thus, the physiological responses of the human endometrium to
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the sex steroid hormones translate to its most important functions:
continuing reproduction of species and prevention of pathology. The
underlying molecular mechanisms of both functions still remain largely
unknown.
The cyclic hormonal changes of the human endometrium were
described in great detail by Noyes and Haman at the morphological and
histological level using human endometrial biopsies collected at
diﬀerent time points of the menstrual cycle (Noyes and Haman,
1953). Their systematic analysis of endometrial biopsies across the
menstrual cycle demonstrated cell proliferation (E2 eﬀect) followed by
a sequence of distinct secretory changes after ovulation (predominant P
eﬀect), ﬁnally culminating in tissue breakdown and menstrual shed-
ding of the endometrium (withdrawal of P). These original studies have
been reﬁned over the years using immunohistochemical (IHC) markers
of cell proliferation, coupled with expression of cell cycle regulated
proteins and steroid receptors that together with quantitative ap-
proaches in staged endometrial biopsies conﬁrmed the Noyes staging
and form the basis of current understanding (Niklaus et al., 2007).
Similarly, global gene expression studies of the whole human endome-
trium deﬁned proliferative, early secretory, mid-secretory and late
secretory endometrium into speciﬁc categories based on transcriptional
and microRNA proﬁles, indicating the signiﬁcance of the coordinated
sequence of molecular events in response to sex steroids (Talbi et al.,
2006; Borthwick et al., 2003; Kuokkanen et al., 2010; Diaz-Gimeno
et al., 2014).
For the past decades Murid species particularly rats and mice have
been used as research models to expand our knowledge on the
regulation of uterine epithelial cell proliferation and diﬀerentiation.
Although these two species do not have menstrual cycles, they show
very similar patterns of responsiveness to E2 and P during their estrous
cycle and subsequent preparation for implantation following copula-
tion as observed in humans during the menstrual cycle. Furthermore
these states can be completely replicated in hormone treated ovar-
iectomized adult females (Tong et al., 2008). Using these species, early
observations resulted in key ﬁndings that pointed to a paradigm of
paracrine signaling in the growth control of the mouse uterine
epithelium. When E2 was administered to neonatal mice, it induced
DNA synthesis in uterine epithelial cells even though E2 binding
activity was not present in these cells that lack ESR1 at this early
developmental stage (Bigsby and Cunha, 1986; Bigsby et al., 1990).
However, unlike the epithelium, the mesenchymal cells of the early
developmental uteri express ESR1, prompting a hypothesis that
signaling from the mesechymal cells would indirectly mediate the
epithelial response to E2. Support for a stromally synthesized factor on
the epithelial proliferative response to E2 came from in vitro experi-
ments where E2 was ineﬀective in inducing mitogenic activity in pure
epithelial cell culture (Tomooka et al., 1986), but showed proliferation
when recombined with stromal cells and grown in xenotransplants
(Cooke et al., 1986). Furthermore, conditional genetic ablation of Esr1
and Pgr in the luminal and glandular epithelium has indicated the
requirement for Esr1 in the stroma for the E2 induction of DNA
synthesis although inhibition by P required PGR expression in these
epithelial cells (Winuthayanon et al., 2010; Franco et al., 2012). These
conditional ablation experiments along with others have further
emphasized reciprocal paracrine signaling between the stroma and
epithelial compartments in the control of uterine preparation for
implantation (Adams and DeMayo, 2015).
Mechanistic studies of endometrial functions in human have been
hindered by the lack of experimental models suitable for reproducing
dynamic changes of the menstrual cycle in this remarkably regenerative
tissue. Observation of the transformation of the human endometrium
during a single menstrual cycle will take approximately 4 weeks and
involve multiple sampling of many women to produce statistically valid
data. As the long-term in vitro culture of endometrial epithelial cells in
combination with stromal cells is diﬃcult, there appears to be a limited
possibility to maintain truly hormonally receptive epithelial cells in
culture for such long duration. Nevertheless, there have been recent
advances enabling the culture of endometrial epithelial organoid
cultures in matrigel that respond to E2 and P with appropriate changes
in gene expression patterns (Turco et al., 2017). However even in these
organoid cultures, the epithelial cells were not shown to proliferate in
response to E2 perhaps because they lack stromal elements. Thus in an
eﬀort to advance our understanding of the mechanisms of steroid
hormone actions in human endometrial functions, a variety of experi-
mental models in vivo have been developed. In this review, we will
discuss the in vivo models that involve the xenotransplantion into
immunodeﬁcient host mice of functional human endometrium using
either endometrial tissue fragments or dispersed endometrial epithelial
and stromal cells that are recombined before implantation.
Additionally, we will discuss the application by our laboratory of the
human endometrial recombined xenograft model for mechanistic
studies to unravel cyclic endometrial changes under the inﬂuence of
E2 and P control.
2. Epithelial and stromal cell tissue recombinants of
endometrium
Genetically engineered mice, in particular Esr1 and Pgr null
mutant mice, were developed to speciﬁcally interrogate the sex steroid
actions in uterine epithelial cell growth (Hamilton et al., 2017; Adams
and DeMayo, 2015). The results from a series of studies using
heterotypic endometrial tissue recombinants of Esr1 and Pgr knockout
mouse models transplanted into mice have shed light on paracrine
interactions regulating mitogenesis of the endometrial epithelium. For
example, analysis of tissue recombinants prepared using the uteri of
wild-type and Esr1 knockout (ERKO) mice demonstrated that E2-
induced epithelial mitogenesis and E2-induced downregulation of PR
in the epithelium is mediated by stromal ESR1 without epithelial ESR1
contribution to this process (Kurita et al., 2000; Cooke et al., 1997). In
a further study, Kurita et al. investigated epithelial and stromal PR
participation in the inhibition of epithelial DNA synthesis using tissue
recombinants of uteri from wild-type and progesterone receptor knock-
out (PRKO) mice (Kurita et al., 1998). The results indicated that
stromal PR mediates the P inhibitory eﬀect on E2-induced uterine
epithelial DNA synthesis, whereas epithelial PGR was not suﬃcient for
this inhibition (Kurita et al., 1998). However, these data from
recombinant tissues are in contradistinction to the targeted ablation
of Pgr in the mouse uterine luminal epithelium that showed the
requirement for epithelial PGR to inhibit E2-induced DNA synthesis
(Franco et al., 2012). Thus, although the tissue recombinant studies
point to the signiﬁcant role of epithelial-stromal paracrine actions in P
control of epithelial cell growth, genetic ablation in a cell type speciﬁc
fashion provided contradictory results. Thus care does need to be taken
in their interpretation as there maybe compensatory mechanism in
play as the recombined tissue is in a foreign environment, the
recombinants do not contain all uterine cell types and the timing of
P action is diﬀerent (Wetendorf and DeMayo, 2014; Vasquez and
Demayo, 2013).
More recently, the role of speciﬁc paracrine factors, such as IGF1
and FGFs, has been identiﬁed to mediate hormonal eﬀects between
epithelial and stromal compartments in the mouse uterus (Zhu and
Pollard, 2007; Li et al., 2011). Pierro et al. described a co-culture
system of human epithelial and stromal cells in which lack of DNA
synthesis prevailed when epithelial cells were cultured alone, but
epithelial DNA synthesis occurred when these cells were co-cultured
with stromal cells and this response was further enhanced by E2 or
IGF1 (Pierro et al., 2001). However, these results to our knowledge
have never been repeated, and indeed, eﬀects were small and only
shown for the incorporation of 3H-thymidine and not on DNA
synthesis into nuclear DNA per cell by autoradiography. Thus, the
changes could be accounted for by eﬀects on alterations in thymidine
pools giving changed 3H-thymidine speciﬁc activity. Nevertheless, at
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face value the observations give some support for the importance of
epithelial-stromal interactions in human endometrial growth and
physiology similar to the mouse uterus.
Kurita et al. applied the tissue recombinant technique with recon-
structed chimeric endometrium composed of human epithelial cells
and mouse stroma from wild-type or ER null mice as well as solely
human endometrium composed of human epithelial and stromal cells
(Kurita et al., 2005). Both mouse/human and human/human tissue
recombinants reorganized into endometrial-like tissue under the
kidney capsule of the nude host mice and were functionally responsive
to E2 (Kurita et al., 2005). Notably, the proliferative response of the
endometrial epithelium to E2 diﬀered between mouse and human
tissue. While the mouse uterine epithelium reached maximum pro-
liferative response to E2 already 16–18 h after administration, human
uterine epithelium required 5–7 days to show maximal proliferation
(Kurita et al., 2005). Interestingly, an extended 7 days of E2 treatment
resulted in the inhibition of mouse epithelial cell proliferation in the
presence of wild-type mouse stroma. Moreover, E2 was ineﬀective in
inducing epithelial proliferation and increase in the expression of PGR
when wild type mouse epithelium was reconstructed with stromal cells
from mice lacking the ESR1 activation function-1 (AF-1) domain. In
contrast, when mouse stromal cells from the ESR1 AF1 null mice were
recombined with human epithelial cell, the epithelium responded with
mitotic activity and increase in PGR (Kurita et al., 2005). These results
suggest that there are species diﬀerences in uterine epithelial response
to E2 and requirement for the estrogen receptor. Although hormonal
responses may be similar, they are unlikely to be identical in the human
and mouse uterus given the mouse estrous cycle lasts 3–4 days and the
human menstrual cycle approximately 28 days. This observation
conﬁrms that a rodent model has limitations to further our under-
standing of endometrial biology in human.
3. Xenotransplant models of human endometrium
To underpin the molecular mechanism underlying endometrial
biology, xenotransplants of human endometrial tissue to host mice
have been developed. In one experimental model investigators have
placed fragments of fresh endometrial tissue (1–2 mm3 in size) in the
subcutaneous space of host mice (here referred to as endometrial
xenotransplants) (Alvarez Gonzalez et al., 2009; Coudyzer et al., 2013,
2015; Zaino et al., 1985; Bergqvist et al., 1985) or allowed fragments of
the human endometrium to adhere to an intact peritoneal surface
(mesothelial layer) to form proliferating endometriosis-like implants
(Nisolle et al., 2000a, 2000b). In the other endometrial xenograft
model, endometrial epithelial and stromal cells are enzymatically
dissociated and then these cells are recombined in a rat-tail collagen
gel and placed under the vascular kidney capsule of host mice to
reconstruct the human endometrium (Fig. 1: here referred to as
endometrial xenografts) (Masuda et al., 2007; Polotsky et al., 2009).
The capacity of endometrial tissue to transplant appears not to depend
on the timing when the fresh endometrium was harvested (Nisolle
et al., 2000a); however most researchers sample the human endome-
trium during proliferative phase. The discovery of immunodeﬁcient
mice tremendously contributed to xenotransplantation research be-
cause these animals possess limited capacity to reject foreign tissue and
thus are ideal hosts. Initial xenograft and xenotransplant models of the
human endometrium used nude mice that have a defective thymus with
T cell deﬁciency (Zaino et al., 1985; Bergqvist et al., 1985; Polotsky
et al., 2009; Zamah et al., 1984). However, subsequently it was
discovered that severe combined immunodeﬁciency (SCID) mice that
lack functional T and B lymphocytes (Alvarez Gonzalez et al., 2009;
Bosma et al., 1983) and, in particular, non-obese diabetic (NOD)
/SCID/γcnull mice (NOG) (Ito et al., 2002) that additionally have
defective NK cell activity and cytokine production showed higher
engraftment rate and improved survival of grafted tissue (Masuda
et al., 2007; Matsuura-Sawada et al., 2005). RAG-2/γ(c) mice that lack
T and B lymphocytes as well as NK cells, but can produce cytokines
were shown to be more suitable for experiments of long duration
because they tend to avoid early graft rejection and therefore have
prolonged survival of the grafted tissue. Indeed, Greenberg and
Slayden reported maintenance of the endometrium-like morphology
in subcutaneous xenotransplants up to the length of 4 hormonally
induced menstrual cycles (Greenberg and Slayden, 2004).
As mentioned earlier there are various types of in vivo research
models of the human endometrium. Both xenotransplant and xenograft
models of the human endometrium vary based on strains of mouse
used, and whether fresh or digested endometrial fragments are used.
Morphological diﬀerence at the histological tissue level has been noted
among diﬀerent host mouse strains. For instance tissue fragments of
the human endometrium grown intraperitoneally or subcutaneously in
the nude mice show various degree of ﬁbrosis around the transplanted
tissue (Bergqvist et al., 1985; Grummer et al., 2001); however such
morphological features are not found in the endometrial xenotrans-
plants and xenografts grown in the severely immunodeﬁcient, SCID
mice (Alvarez Gonzalez et al., 2009; Nisolle et al., 2000b; Masuda et al.,
2007). Fibrosis around the grafted tissue may be detrimental for proper
endometrial function by inhibiting adequate vascularization of the
implanted tissue and therefore SCID mice appear to be a better host of
both human endometrial xenotransplants and xenografts. However, it
should be noted that we did not ﬁnd signiﬁcant ﬁbrosis around our
human endometrial xenografts when dissociated epithelial and stromal
cells were recombined and placed under the kidney capsule of nude
mice (Polotsky et al., 2009), thus suggesting variations in technique or
graft site may play a role in this process.
Engraftment of the human endometrial biopsy fragments placed
into the subcutaneous space or in intraperitoneal locations of host mice
occurs already a few days after implantation. These xenotransplants
survive for up to 4 weeks. While implantation and preservation of
normal morphology of transplanted endometrial biopsy fragments is
not dependent on sex steroid hormone, E2 is required for epithelial
proliferation and expression of estrogen and progesterone receptors in
the xenotransplanted tissue (Matsuura-Sawada et al., 2005; Grummer
et al., 2001; Aoki et al., 1994). In contrast, when dissociated epithelial
and stromal cells are recombined in rat collagen and placed beneath
the kidney capsule of ovariectomized host mice, E2 is essential for
engrafting as well as for adequate growth and diﬀerentiation of grafted
endometrial tissue (Masuda et al., 2007; Polotsky et al., 2009). In this
model endometrial-like tissue with well-delineated glands and stroma
is found in the xenografted outgrowths typically after 3 weeks of
estrogen treatment (Masuda et al., 2007; Polotsky et al., 2009) that is
most eﬀectively administered through subcutaneous hormone releas-
ing pellets or oil deposits (Fig. 1). Matsuda et al. reported a 100% take
rate of reconstructed xenografts of human dissociated endometrial
epithelial and stromal cells in E2-treated NOG mice (Masuda et al.,
2007) compared to 30–40% take rate reported in nude mice (Polotsky
et al., 2009). The high take rate of xenografts in NOG mice was
attributed to the profound state of immune deﬁciency of these animals.
The advantages of the high take rates in NOG mice enable the use of
one endometrial biopsy for several grafts, thereby enhancing the
experimental homogeneity and eﬃciency. The timing of ovariectomy
for the removal of endogenous sex steroid inﬂuence has varied between
diﬀerent studies. However similar take rates were reported regardless
of whether the host animals were ovariectomized 1–2 weeks prior to, at
the time of, or after the establishment of xenotransplants using
endometrial tissue fragments.
4. Human origin of the endometrial xenotransplants and
xenografts
Researches have used human speciﬁc markers to conﬁrm the origin
of xenotransplanted and xenografted endometrial tissue. For example,
immunohistochemical staining of intraperitoneally implanted frag-
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ments of human endometrial biopsies indicated staining patterns of
glandular epithelial and stromal cells of exclusively human origin using
antibodies speciﬁc for human cytokeratin and vimentin, respectively
(Grummer et al., 2001). In agreement, Matsuda and colleagues
performed immunoﬂuorescence staining of human endometrial xeno-
grafts with human anti-vimentin known to recognize only human
vimentin and conﬁrmed the human source of reconstructed endome-
trial-like tissue (Masuda et al., 2007). Our group, on the other hand,
performed in-situ-hybridization staining with a probe speciﬁc to
human Alu-sequence and showed selective positive hybridization in
the endometrial epithelium and stroma of the xenograft and none in
the adjacent mouse kidney parenchyma (Polotsky et al., 2009).
Additionally, staining with Hoechst 33258 that shows distinct mor-
phology for mouse and human nuclei can be used to conﬁrm human
origin of the endometrial grafts (Cunha and Vanderslice, 1984). These
methods indicate that the human endometrial xenotransplants and
xenografts have largely preserve the endometrial cellular composition
of their original species source.
5. Neovascularization of human endometrial
xenotransplants and xenografts
Angiogenesis is the process by which new microvessels develop
from the existing vessels and is essential for the survival and growth of
the human endometrial grafted tissue (Nap et al., 2004). The origins of
neovasculature in endometrial xenotransplants xenografts remain
Fig. 1. Schematic of Human Endometrial Biopsy and Analysis. After screening and informed consent an endometrial biopsy is taken with a pipelle catheter from women
volunteers usually in the proliferative stage of the menstrual cycle. These biopsies are washed in McCoy's media and minced into pieces and subjected to enzymatic dissociation with
collagenase and DNase I at 37 °C with shaking as described (Polotsky et al., 2009). After digestion cells were collected by centrifugation and ﬁltered through sterilized 85uM nylon mesh
ﬁlters. Retained tissue from the ﬁrst ﬁltration was digested with 0.5% w/v hyaluronidase, 0.5% w/v protease and DNase I in McCoy's medium for 20 min. In this fashion, the epithelial
cells are segregated as organoids containing several glands in an eﬀort to preserve physiological tissue orientation (Kurita et al., 2005). The ﬁltrate from the ﬁrst ﬁltration containing the
stromal cells is then separated from the remaining red blood cells with a one-layer Percoll density gradient. In order to obtain a single cell preparation of stromal cells, the suspension
was then passed through a sterilized 20 mm nylon mesh ﬁlter. In general, one endometrial biopsy yielded 10–20 million of epithelial and stromal cells suﬃcient for grafting 10–20 hosts.
This method also yields pure isolates of stromal and epithelial compartments of human endometrium for analysis. In principle these cells can then be transfected or infected with
lentiviruses to allow genetic manipulation using for example, the CRISPR/CAS9 system. However, to date this has only been performed to enable luciferase expression. To prepare
xenotransplants freshly isolated uterine stromal cells and epithelium are recombined in 30 mL of rat-tail collagen gel by placing three to ﬁve epithelial organoids and approximately
500,000 stromal cells per tissue recombinant. The recombinants are allowed to gel under room temperature. Kidney grafting into nude mice is conducted via a dorsal incision under
anesthesia (http://mammary.nih.gov/tools/mousework/Cunha001/index.html). One xenograft is implanted under each kidney capsule of each adult intact 8–10-week-old female nude
mice. Usually mice are ovariectomized at the same time and an implant of E2 is given. After allowing 6 weeks for tissue outgrowth the implant is removed and the mice rested before
hormonal treatment (Fig. 2). These procedures give a xenotransplant with recognizable endometrial structures containing epithelial glands and stroma overlaid on the kidney of the mice
as shown. Following hormone treatment the tissue can be analyzed using many diﬀerent techniques including IHC, laser capture micro-dissection of individual cellular compartments
and real time PCR or RNA sequencing to determine transcriptional changes. The method will become even more valuable as technology improves to use multi-parametric analysis on a
single cell basis in tissue sections.
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controversial and may in fact vary depending on the strain of the host
mice (Alvarez Gonzalez et al., 2009; Masuda et al., 2007; Grummer
et al., 2001; Bruner-Tran et al., 2002a; Eggermont et al., 2005). In the
earlier studies, endometrial lesions transplanted into a nude or SCID
mice were reported to obtain their vascular supply from the surround-
ing host vascular network, whereas the pre-existing vessels of human
origin gradually disappeared (Grummer et al., 2001; Bruner-Tran
et al., 2002b). Grummer et al. stained vessels of human origin with
human speciﬁc anti-vWF antibody and mouse endothelia of a rat anti-
mouse pan-endothelial cell antibody and demonstrated that the vessels
within endometrial transplants were only of mouse origin (Grummer
et al., 2001). In contrast, Masuda et al. demonstrated vessels of human
origin throughout the endometrial xenografts that were reconstructed
by recombining dissociated epithelial and stromal cells and placing
them under the kidney capsule of NOG mice (Masuda et al., 2007).
Moreover, these human-derived vessels were shown to invade into the
mouse kidney parenchyma where they become connected to mouse
vessels, thus forming chimeric vessels (Masuda et al., 2007). Because
the NOG mice are severely immunodeﬁcient and lack NK cells, it was
proposed that the lack of NK cells allowed the neovascularization of
vessels of human origin within the xenografts. However, Alvarez
Gonzalez et al. subsequently showed vessels of human origin within
the human xenotransplants implanted subcutaneously in both nude
and SCID mice (these immunodeﬁcient mice have intact NK cells).
Additionally, throughout the endometrial xenotransplants they ob-
served chimeric vessels in which vessels staining positive for human
markers were connected to those of murine origin (Alvarez Gonzalez
et al., 2009). It is plausible that the location of the ectopically
reconstructed endometrium and adjacent vascular environment also
inﬂuences how and from which source the neovascularization of the
graft develops. However, in no cases have the mechanisms behind the
vascularization of the grafts been analyzed.
6. Xenotransplanted human endometrium responds to sex
steroid hormones
In order for xenotransplanted and xenografted endometrial tissue
to undergo similar dynamic changes to that of human eutopic
endometrium under the inﬂuence of sex steroids, their cognate steroid
hormone receptors, ESR1 and PGR need to be expressed in the tissue.
In ovariectomized and untreated host mice, immunohistochemical
staining of endometrial xenotransplants with anti-ESR1 demonstrated
robust expression of ESR1 in glandular epithelium and weaker staining
in the stroma (Polotsky et al., 2009). It is well established that while E2
down-regulates its own receptor, ESR1, in the normal human endome-
trium, it increases PGR expression. Consistent with the human eutopic
endometrium, treatment of ovariectomized host mice with E2 resulted
in down-regulation of ESR1 in the endometrial xenografts of dispersed
and recombined epithelial and stromal cells compared to those without
hormonal exposure (Polotsky et al., 2009). The treatment with E2 also
resulted in up-regulation of PGR in both epithelial and stromal
compartment of these human endometrial xenografts (Masuda et al.,
2007; Polotsky et al., 2009). Furthermore, glandular epithelial cells
became pseudostratiﬁed and stained positive for anti-MCM2 and anti-
MKI67 (markers of cell proliferation) as an indication of E2-induced
cell proliferation (Masuda et al., 2007; Polotsky et al., 2009). The
endometrial responses of the xenografts to E2 are thus comparable to
those found in eutopic human endometrium.
Menstruation, that is cyclic shedding of the functionalis layer of the
endometrium induced by P withdrawal, is a unique event of the human
and Old World primates. Models of menstruation have successfully
been developed based on xenotransplantation of human endometrial
biopsy fragments into the subcutaneous space of SCID (Guo et al.,
2011) and NOG host mice (Matsuura-Sawada et al., 2005) and in
endometrial xenograft models reconstructed using dispersed epithelial
and stromal cells that are recombined and implanted under the kidney
capsule of NOG mice host mice (Masuda et al., 2007). After formation
of xenotransplants and xenografts, ovariectomized host animals were
cyclically treated with E2 for 2–3 weeks and then E2 plus P for another
14 days to induce an artiﬁcial menstrual cycle (Masuda et al., 2007;
Matsuura-Sawada et al., 2005). In these models E2 administration
induces proliferative changes in endometrial epithelial cells whereas E2
plus P treatment inhibit this cell proliferation and additionally trans-
forms epithelial cells into the secretory phase. Furthermore, P treat-
ment induced predecidualization changes in stromal compartment of
E2-primed xenotransplants and reconstructed xenografts (Masuda
et al., 2007; Matsuura-Sawada et al., 2005). In particular, stromal
edema and increased expression of prolactin, a marker of decidualiza-
tion, were observed in stromal cells that morphologically had trans-
formed to typical large and round decidualized cells (Masuda et al.,
2007). Similar to human decidualized endometrium a large number of
CD45-positive leukocytes, including CD56-positive NK cells and CD14-
positive cells, both of human origin, has been reported to be abundant
in the grafted tissue following 28 days of hormone treatment in NOG
host mice (Masuda et al., 2007).
In ovariectomized mice, destruction of xenografted stromal tissue
and glandular structures as well as sloughing of luminal epithelium can
be seen approximately one week after withdrawal of P in the human
endometrial xenografts that were created by recombining dispersed
epithelial and stromal cells and which were implanted under the kidney
capsule of the NOG host mice (Masuda et al., 2007). Also, blood-ﬁlled
cysts are formed in these endometrial tissue reconstructs because the
lumen of the endometrial xenotransplant lacks an outﬂow tract
preventing the escape of blood (Masuda et al., 2007). Interestingly,
after the phase of “menstrual” destruction following the cessation of E2
and P4 supplementation, endometrial xenotransplants created using
endometrial fragments into the subcutaneous space of ovariectomized
NOG host mice quickly return to proliferative phase (Matsuura-Sawada
et al., 2005). These results not only suggest that the early growth phase
of the endometrium is indeed independent of estrogen, but also
indicates that xenotransplants of the human endometrium have
signiﬁcant regenerative capacity similar to the eutopic endometrium.
Traditionally, the human endometrium is believed to regenerate from
the basalis layer that persists after menstruation (Padykula, 1991).
However, the basalis layer is absent from xenotransplants and yet these
lesions have signiﬁcant regenerative capacity, which raises the possi-
bility that endometrial stem/progenitor cells present in the functionalis
layer may contribute to the physiological regeneration of the endome-
trium. Further research is needed to clarify this possibility.
7. Functional studies using xenotransplanted human
endometrium
The endometrial xenotransplant model using dissociated epithelial
and stromal cells that are recombined beneath the kidney capsule of
immunodeﬁcient mice presents a novel experimental opportunity to
investigate endometrial functions. For example, Matsuda et al. lentivi-
rally engineered human dispersed endometrial cells to express lucifer-
ase prior to grafting and in this fashion non-invasively and quantita-
tively were able to track hormone induced cellular changes by in vivo
bioluminescent imaging (Masuda et al., 2007).
In our previous studies, we used reconstructed xenograft model of
dissociated human endometrial epithelial and stromal cells into the
kidney capsule of nude mice to deﬁne molecular mechanisms under-
lying endometrial epithelial cell proliferation by E2 (Polotsky et al.,
2009). Speciﬁcally, we investigated whether similar cellular mechan-
isms were operative in the human endometrium as previously dis-
covered in the mouse uterus. In the mouse, inhibition of glycogen
synthase kinase 3ß (GSK3ß) under the inﬂuence of E2 is a key event
that results in the nuclear localization of cell cycle regulatory molecule,
cyclin D1 in the uterine epithelium (Chen et al., 2005). Nuclear cyclin
D1, in turn, together with its partners CDK4 and CDK6 phosphorylates
S. Kuokkanen et al. Differentiation 98 (2017) 62–69
66
pRB with subsequent dramatic increase in cyclin A and elevation of
CDK2 causing further phosphorylation of pRB, coincident with pro-
gression of epithelial cells towards S-phase of the cell cycle, thus DNA
synthesis (Chen et al., 2005). In the mouse uterus, our group previously
showed that targeted inhibition of GSK3ß by a chemical inhibitor,
lithium chloride was permissive for uterine epithelial cells to undergo
DNA synthesis even in the absence of E2 (Chen et al., 2005). In this
context, we biochemically inhibited GSK3ß by adding lithium to the
drinking water of the host nude mice carrying the endometrial
xenografts (Polotsky et al., 2009) which resulted in nuclear accumula-
tion of cyclin D1 and proliferation of epithelial cells of the xenografts in
the absence of E2 (Polotsky et al., 2009). These results indicate that
similar to the mouse uterine epithelium E2 signaling occurred through
GSK-3ß inhibition in the epithelium of the human reconstructed
endometrial xenograft.
Using an identical xenograft model in nude mice, we have further
explored the proliferative response of the human endometrial epithe-
lium to E2 and P. In these experiments, the host nude mice were
treated with E2 or E2 plus P in regimens designed to mimic the human
menstrual cycle (Fig. 2A), followed by immunohistochemical staining
of the xenografs with MKI67 antibody (marker for cell proliferation) at
diﬀerent time points (Fig. 2B). In the E2 treated group compared to the
untreated group, the ﬁrst proliferative response in the epithelial cells
was observed after 16 h of treatment. Despite the continued E2
treatment, after 3 days of E2 treatment, the epithelial cells reduce
their proliferation and the proportion of the epithelial cells proliferat-
ing returned to that of untreated control epithelial cells. Interestingly, a
second and maximal wave of proliferation occurred after 5 days of E2
with approximately 22% of epithelial cells staining positive to MKI67
compared to the control epithelial cells. P reduced this proliferative
response to untreated control levels when E2 and P were co-adminis-
tered to the animals for ﬁve days (Fig. 2B). This indication of two waves
of DNA synthesis in response to E2 in human endometrial epithelium
(Fig. 2B) is reminiscent, although on an expanded time-scale to that
seen in mice (Martin et al., 1973). Detection of such kinetics would be
impossible to detect in human endometrial biopsies, but this observa-
tion aligns responses in mouse and humans together.
Analysis of mini-chromosome maintenance protein (MCM)2 ex-
pression that is a pre-replication licensing factor essential for DNA
synthesis and whose concentration, nuclear localization and activity is
stimulated by E2 but inhibited by P, also showed a similar readout but
with a greater percentage of cells staining positive for nuclear MCM2
than MIK67 (Fig. 2C,D). Thus, MCM2 may represent a more sensitive
indicator of DNA synthesis than MKI67. It also shows again a similarity
with the stimulation of mouse uterine DNA synthesis by E2 and
inhibition by P. Indeed the inhibition of E2 induced DNA synthesis
by P shows that these xenotransplants are not P insensitive as observed
in endometriosis (Kao et al., 2002). Thus, they appear to more closely
represent functional endometrium than transplants of endometrial
tissue into the peritoneal cavity that resemble implants of endome-
triosis. Interestingly, in mice the regulation of MCM2 expression is in
part controlled by the Kruppel-like transcriptions factors (KLF) 4 and
15 with the latter mediating the negative inhibition by P (Ray and
Pollard, 2012). In human endometria KLF15 has recently been shown
to be deregulated in eutopic endometria of patients with endometriosis
(Kim et al., 2015). These patients are P insensitive suggesting that
similar mechanisms to those observed in mice are present in humans.
Manipulation of these human endometrial xenografts could allow this
observation to be examined experimentally and perhaps also to
indicate therapeutic opportunities in humans.
The xenografted stromal compartment regenerates to surround
endometrial glands; however, in our series using nude mice as a host,
the abundance of the stroma remains limited and therefore this model
appears to be better suited for the study of the luminal and glandular
epithelium. Indeed we have had diﬃculty in showing reliable stromal
proliferative responses to E2 and P. Despite the extensive regenerative
capacity of dissociated and recombined endometrial epithelial and
stromal cells, the main disadvantage of the human endometrial
xenograft model is the limited amount of tissue that can be harvested
from each tissue outgrowth. For this reason, the genetic material needs
to be ampliﬁed prior to gene expression proﬁling; and moreover,
quantitative protein assays including Western blot and large-scale
proteomics are not to date feasible (Fig. 1).
Fig. 2. In human tissue xenotransplants E2 induces two waves of DNA
synthesis and this is inhibited by Progesterone. (A) 6 weeks after transplantation
E2 implants are removed and mice rested for two weeks. Mice after priming with two
daily subcutaneous injections (sc) of 100 ng E2/mouse were divided into groups of two to
ﬁve animals per group according to the following sc treatments: 5 days of daily: (a)
0.1 mL peanut oil; b) 125 ng of E2 in peanut oil; c) 1 mg Progesterone (P4) plus 125 ng
E2 in peanut oil. Animals were killed at the times indicated after the ﬁrst E2 injection
(except for E2 that was also given for 7 days). Each experiment was repeated at least
twice. (B) After the hormonal treatments shown mice were killed, kidneys isolated and
xenotransplants ﬁxed. After embedding and sectioning at 5 μM they were then subjected
to immunohistochemistry for MKI67 as described (Polotsky et al., 2009). The percent of
nuclear positive cells in the epithelial compartment was determined according to
hormonal treatment. Maximal E2-induced DNA synthesis was at 5 days and this was
inhibited to control levels by concurrent treatment with P4. Statistical analysis shown by
ANOVA. (C) The same sections as in B were also immunostained for MCM2 as described
(Polotsky et al., 2009). MCM2 nuclear positive cells shown below in the representative
histology (D) were enumerated for control oil treated mice, E2 treated mice for 5 days
and P4E2 mice for 5 days. Positive immunohistochemical nuclear stain given by anti-
MCM2 antibody is brown in 5 μM sections counter stained with Haematoxylin for the
treatments indicated by the arrows. E2 signiﬁcantly increased the number of MCM2
positive cells to ~80% and this is inhibited to below the control level by P4 treatment.
Students T test P > 0.05 considered signiﬁcant.
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8. Xenotransplants and xenografts of the human
endometrium for testing of compounds
The idea that the eﬀect of novel compounds on the human
endometrium could be tested using an in vivo model without giving
them to women is quite intriguing. In our experiments as described
above, we administered lithium chloride to host animals to inhibit
GSK-3ß and investigated its eﬀect on endometrial cell proliferation.
Even though lithium is a therapeutic agent used for bipolar disorder, it
has potential renal toxicity and accordingly, its administration to
volunteer women solely for research purposes would be unethical.
Amaya et al. studied the eﬀect of resveratrol (a natural phytoestrogen
found in red wine, grapes, and berries) on endometrial cell prolifera-
tion in the xenotransplant model of endometrial fragments placed in
the subcutaneous space of the host RAG-2/γ(c) mice (Amaya et al.,
2014). Compared to the E2 treated group, E2 plus a high dose
resveratrol treatment decreased immunostaining of MKI67 and ESR1
in the epithelium of the xenotransplants, suggesting this compound
reduces epithelial proliferation possibly through downregulation of
ESR1, and therefore acts as a partial estrogen antagonist in the
endometrial epithelium (Amaya et al., 2014). In another study the
investigators examined the endometrial eﬀects of the progestogen,
levonorgestrel (LNG) that is a highly eﬃcient contraceptive in the form
of a LNG releasing intrauterine system (IUS). In this study the authors
used fragments of human endometrium that were implanted in
subcutaneous space of SCID host mice to create endometrial xeno-
transplants (Alvarez Gonzalez et al., 2009). Subsequently, mice carry-
ing these endometrial xenotransplants were treated with E2 or E2 plus
LNG for a total of 4 weeks after which endometrial morphology was
evaluated and compared to human eutopic proliferative endometrium
and human endometrium exposed to LNG-IUS. After 4 weeks of
treatment, all xenotransplants from the mice treated with LNG
presented morphology and cell proliferation pattern similar to those
observed in the endometrium exposed to LNG-IUS. These features
included decreased glandular epithelial cell proliferation, atrophy of
glandular cells and stromal decidualization (Alvarez Gonzalez et al.,
2009). Similarly, the steroid receptor status of the xenotransplants in
LNG-treated mice mimicked the expression pattern to the LNG-IUS-
treated human eutopic endometrium, including decrease in stromal
and glandular PGR expression and reduction in stromal ESR1 (Alvarez
Gonzalez et al., 2009). Hence, there are several examples describing the
feasibility of human endometrial xenografts and xenotransplants as an
invaluable tool to study endometrial eﬀects of various compounds.
These models are particularly advantageous when there are practical
and ethical limitations in administering compounds to humans.
Moreover, this in vivo animal model can be suitable to evaluate
possible eﬃcacy of various therapeutic modalities for endometrial
disease prior to testing in women with these conditions.
9. Concluding remarks
Decades of research has revealed a critical role of paracrine
signaling in regulating endometrial cell growth and diﬀerentiation that
has led to the development of in vivo models for the study of the
physiology of normal endometrium. When recombined, isolated hu-
man epithelial and stromal cells have the capacity to regenerate and
reconstitute the endometrium ectopically with normal tissue organiza-
tion, endometrial cellular components and responsiveness to sex
steroids. The capacity of endometrial xenografts to respond to steroid
hormones and regenerate conﬁrms this model as a powerful tool for the
study of hormone eﬀects in endometrial tissue over the course of a
menstrual cycle. A real beneﬁt of the xenotransplants and xenograft
models is that one endometrial biopsy provides tissue for several
endometrial xenografts, thus limiting the number of women needed for
biopsy, yet allowing a decent number of experimental replicates. Tissue
xenograft of the human endometrium oﬀers means to deﬁne molecular
factors and pathways operational in endometrial physiology, including
control of cell proliferation, stromal decidualization and degeneration.
Importantly, the model provides novel avenues for the study of human
endometrial biology that were not previously possible because the
xenograft model using dispersed endometrial cells recombined under
the kidney capsule of recipient mice allows application of manipulative
molecular tools, such as CRIPS-CAS9 technology to knock-out genes of
interest in cell-speciﬁc fashion in xenografted tissue (Fig. 1). In
addition, the dramatic advances in genetic sequencing technology
and multi-parameter protein detection at the single cell level will allow
the state of individual cells to be interrogated in vivo in a controlled
hormonal environment. Furthermore, advances in organiod culture
technology of endometrial glandular epithelial cells and endometrial
ﬁbroblasts raises the possibility of genetic manipulation, selection for
positive alterations, followed by recombination into functional hor-
monally responsive xenografts into the kidney capsule followed by
endocrine treatment to deﬁne regulated pathways controlling prolif-
eration and other endometrial functions. These new exciting techni-
ques will surely lead to rapid advances in our understanding of human
endometrial biology. Accordingly, these investigational tools holds
promise to yield mechanistic discoveries of endometrial functions in
human that will be critical for understanding the etiology of endome-
trial pathologies and ultimately the development of targeted therapies
of endometrial disease. Moreover, this model is proposed for the
assessment of potentially harmful biochemical compounds, such as
novel drugs, that may impact the endometrium, but cannot be
administered to women.
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